Eagle's Eye View: Your Weekly CV Update From ACC.org Short-term DAPT, PCI & High Bleeding Risk; Dapagliflozin & Heart Failure; Non-Pharmacologic Treatment of HF
6 snips
Mar 12, 2025 AI Snips
Chapters
Transcript
Episode notes
Short-Term DAPT Works Equally in Men and Women
- Short-term dual antiplatelet therapy (DAPT) shows similar effectiveness and bleeding risks in men and women after PCI.
- Women with obstructive coronary disease benefit from shortened DAPT durations just as men do.
Dapagliflozin Benefits Severe Heart Failure
- Dapagliflozin reduces cardiovascular death and heart failure hospitalization across all severity levels and ejection fractions.
- Even patients with advanced heart failure benefit from this SGLT2 inhibitor.
Non-Pharmacologic Heart Failure Treatments
- Use diet modifications like DASH or Mediterranean diets to manage heart failure, focusing on sodium restriction.
- Employ exercise training and address sleep disorders to improve heart failure morbidity and function.